These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22339634)

  • 1. Construction of TNF-binding proteins by grafting hypervariable regions of F10 antibody on human fibronectin domain scaffold.
    Petrovskaya LE; Shingarova LN; Kryukova EA; Boldyreva EF; Yakimov SA; Guryanova SV; Novoseletsky VN; Dolgikh DA; Kirpichnikov MP
    Biochemistry (Mosc); 2012 Jan; 77(1):62-70. PubMed ID: 22339634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monobodies: antibody mimics based on the scaffold of the fibronectin type III domain.
    Koide A; Koide S
    Methods Mol Biol; 2007; 352():95-109. PubMed ID: 17041261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
    Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional comparisons of different tumour necrosis factor receptor/IgG fusion proteins.
    Scallon BJ; Trinh H; Nedelman M; Brennan FM; Feldmann M; Ghrayeb J
    Cytokine; 1995 Nov; 7(8):759-70. PubMed ID: 8664442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion protein of CDR mimetic peptide with Fc inhibit TNF-alpha induced cytotoxicity.
    Qin W; Feng J; Li Y; Lin Z; Shen B
    Mol Immunol; 2006 Feb; 43(6):660-6. PubMed ID: 15878201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel domain antibody rationally designed against TNF-alpha using variable region of human heavy chain antibody as scaffolds to display antagonistic peptides.
    Qin W; Feng J; Li Y; Lin Z; Shen B
    Mol Immunol; 2007 Mar; 44(9):2355-61. PubMed ID: 17125837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of an interloop disulfide bond in high-affinity antibody mimics based on fibronectin type III domain and selected by yeast surface display: molecular convergence with single-domain camelid and shark antibodies.
    Lipovsek D; Lippow SM; Hackel BJ; Gregson MW; Cheng P; Kapila A; Wittrup KD
    J Mol Biol; 2007 May; 368(4):1024-41. PubMed ID: 17382960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions.
    Sidhu SS; Li B; Chen Y; Fellouse FA; Eigenbrot C; Fuh G
    J Mol Biol; 2004 Apr; 338(2):299-310. PubMed ID: 15066433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-classical binding of a polyreactive α-type anti-idiotypic antibody to B cells.
    Hernández T; de Acosta CM; López-Requena A; Moreno E; Alonso R; Fernández-Marrero Y; Pérez R
    Mol Immunol; 2010; 48(1-3):98-108. PubMed ID: 20952071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel human scFv fragment against TNF-alpha from de novo design method.
    Chang H; Qin W; Li Y; Zhang J; Lin Z; Lv M; Sun Y; Feng J; Shen B
    Mol Immunol; 2007 Jul; 44(15):3789-96. PubMed ID: 17485112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-alpha binds to the N-terminal domain of fibronectin and augments the beta 1-integrin-mediated adhesion of CD4+ T lymphocytes to the glycoprotein.
    Alon R; Cahalon L; Hershkoviz R; Elbaz D; Reizis B; Wallach D; Akiyama SK; Yamada KM; Lider O
    J Immunol; 1994 Feb; 152(3):1304-13. PubMed ID: 7905501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fibronectin type III domain as a scaffold for novel binding proteins.
    Koide A; Bailey CW; Huang X; Koide S
    J Mol Biol; 1998 Dec; 284(4):1141-51. PubMed ID: 9837732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and characterization of a genetically engineered anti-caffeine camelid antibody and its use in immunoaffinity chromatography.
    Franco EJ; Sonneson GJ; DeLegge TJ; Hofstetter H; Horn JR; Hofstetter O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(2):177-86. PubMed ID: 19560409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A conformation-constrained peptide library based on insect defensin A.
    Zhao A; Xue Y; Zhang J; Gao B; Feng J; Mao C; Zheng L; Liu N; Wang F; Wang H
    Peptides; 2004 Apr; 25(4):629-35. PubMed ID: 15165719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
    Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.
    Scherf U; Benhar I; Webber KO; Pastan I; Brinkmann U
    Clin Cancer Res; 1996 Sep; 2(9):1523-31. PubMed ID: 9816329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of tumour-necrosis-factor-alpha-specific affibody molecules capable of blocking receptor binding in vitro.
    Jonsson A; Wållberg H; Herne N; Ståhl S; Frejd FY
    Biotechnol Appl Biochem; 2009 Aug; 54(2):93-103. PubMed ID: 19545237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody mimics based on human fibronectin type three domain engineered for thermostability and high-affinity binding to vascular endothelial growth factor receptor two.
    Parker MH; Chen Y; Danehy F; Dufu K; Ekstrom J; Getmanova E; Gokemeijer J; Xu L; Lipovsek D
    Protein Eng Des Sel; 2005 Sep; 18(9):435-44. PubMed ID: 16087651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the domain pairing in chimeric antibodies.
    Teplyakov A; Obmolova G; Carton JM; Gao W; Zhao Y; Gilliland GL
    Mol Immunol; 2010 Aug; 47(14):2422-6. PubMed ID: 20554002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Directed evolution of high-affinity antibody mimics using mRNA display.
    Xu L; Aha P; Gu K; Kuimelis RG; Kurz M; Lam T; Lim AC; Liu H; Lohse PA; Sun L; Weng S; Wagner RW; Lipovsek D
    Chem Biol; 2002 Aug; 9(8):933-42. PubMed ID: 12204693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.